Showing results (751-760 of 889) with videos related to
Sort By:
Pageof 89
Drugs in R&D|May 22, 2003
Oxymorphone--Endo/Penwest: EN 3202, EN 3203Drugs in R&D|April 30, 2003
Phase II study of antineoplaston A10 and AS2-1 in patients with recurrent diffuse intrinsic brain stem glioma: a preliminary reportStanislaw R Burzynski, Robert I Lewy, Robert A Weaver, et al.Drugs in R&D|October 18, 2019
The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT StudyAndreas Muehler, Hella Kohlhof, Manfred Groeppel, et al.Drugs in R&D|August 29, 2018
New Insights on the Pharmacokinetics of Ulifloxacin After Administration of Prulifloxacin in Patients with Mild, Moderate and Severe Renal ImpairmentValeria Tellone, Paola Coppola, Marco Ammendola, et al.Drugs in R&D|May 19, 2017
Pharmacokinetic Bioequivalence Studies of an Extended-Release Oxycodone Hydrochloride Tablet in Healthy Japanese Subjects Under Fasting and Fed Conditions Without an Opioid AntagonistKaoru Toyama, Hidetoshi Furuie, Kana Kuroda, et al.Drugs in R&D|April 18, 2019
Bortezomib for the Treatment of Hematologic Malignancies: 15 Years LaterPawel Robak, Tadeusz RobakDrugs in R&D|May 11, 2019
A Novel, Dose-Adjusted Tacrolimus Trough-Concentration Model for Predicting and Estimating Variance After Kidney TransplantationJanet Kim, Sam Wilson, Nasrullah A Undre, et al.Drugs in R&D|May 23, 2019
Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UKKristina S Boye, Dara Stein, Louis S Matza, et al.Drugs in R&D|November 24, 1999
Endothelin receptor antagonists. Promising new agents in the management of cardiovascular disordersJ Goddard, D J WebbDrugs in R&D|November 24, 1999
Promising new agents in the prevention of transplant rejectionC Ponticelli, A TarantinoPageof 89